Catalyst Crew Technologies Corp. (OTC: CCTC) announced on March 20, 2026, that it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval to change its corporate name to LataMed AI Corp. and to adopt a new trading symbol. The proposed changes aim to better reflect the company's strategic focus on artificial intelligence-enabled healthcare technology, with an initial emphasis on Latin America.
According to the press release, the company's Board of Directors and majority shareholder have approved the name change, which does not involve any reverse stock split, forward stock split, recapitalization, or alteration to the company's capital structure. The issued and outstanding share count will remain unchanged, and shareholders are not required to take any action. The company plans to file a Certificate of Amendment with the Nevada Secretary of State upon FINRA approval, and the changes would become effective after required filings and publication by FINRA on the Daily List.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated that the proposed name change is intended to align the company's public identity with its healthcare technology strategy and long-term market focus. The company, which has not yet generated revenues from its new business direction, is actively pursuing opportunities in telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. More information is available on the company's website at https://catalystcrewai.com and through its SEC filings at www.sec.gov.
The name change and symbol change are subject to FINRA approval, and no assurance can be given regarding the timing or outcome. The company emphasized that this action does not affect shareholders' ownership interests. This announcement underscores Catalyst Crew Technologies' continued transition from its previous operations toward becoming a healthcare technology entity focused on emerging markets.
